Search research articles
Contact Us
Filters
Showing results (221-230 of 299) with videos related to
Page
of 30
Sort By:
Journal of the American College of Cardiology
|
October 29, 2013
AMG 145, a monoclonal antibody against PCSK9, facilitates achievement of national cholesterol education program-adult treatment panel III low-density lipoprotein cholesterol goals among high-risk patients: an analysis from the LAPLACE-TIMI 57 trial (LDL-C assessment with PCSK9 monoclonal antibody inhibition combined with statin thErapy-thrombolysis in myocardial infarction 57)
Nihar R Desai, Robert P Giugliano, Jing Zhou, et al.
Spectrochimica Acta. Part A, Molecular and Biomolecular Spectroscopy
|
November 9, 2007
EPR spin probe study of polymer associative systems
A M Wasserman, L L Yasina, M V Motyakin, et al.
European Journal of Heart Failure
|
October 10, 2009
The safety and tolerability of darbepoetin alfa in patients with anaemia and symptomatic heart failure
Marc Klapholz, William T Abraham, Jalal K Ghali, et al.
American Journal of Public Health
|
November 2, 2018
Trends and Racial Disparities of Late-Stage HIV Diagnosis: Hawaii, 2010-2016
Fenfang Li, Brandi K Juan, Michelle Wozniak, et al.
Parasitology Research
|
May 9, 2018
Prevalence and genotyping of Echinococcus granulosus in sheep in Narok County, Kenya
D O Odongo, C M Tiampati, E Mulinge, et al.
The Journal of Nutrition, Health & Aging
|
June 9, 2020
Editorial: Diagnostic Testing for SARS-Coronavirus-2 in the Nursing Facility: Recommendations of a Delphi Panel of Long-Term Care Clinicians
M Wasserman, J G Ouslander, A Lam, et al.
Nature
|
October 20, 1994
Long-term uncoupling of chloride secretion from intracellular calcium levels by Ins(3,4,5,6)P4
M Vajanaphanich, C Schultz, M T Rudolf, et al.
Journal of Clinical Pharmacology
|
November 19, 2016
Impact of Target-Mediated Elimination on the Dose and Regimen of Evolocumab, a Human Monoclonal Antibody Against Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9)
John P Gibbs, Sameer Doshi, Mita Kuchimanchi, et al.
Journal of the American College of Cardiology
|
April 3, 2014
Anti-PCSK9 monotherapy for hypercholesterolemia: the MENDEL-2 randomized, controlled phase III clinical trial of evolocumab
Michael J Koren, Pernille Lundqvist, Michael Bolognese, et al.
American Heart Journal
|
February 28, 2016
Rationale and design of the Further cardiovascular OUtcomes Research with PCSK9 Inhibition in subjects with Elevated Risk trial
Marc S Sabatine, Robert P Giugliano, Anthony Keech, et al.
Page
of 30
Search research articles
Search
Showing results (221-230 of 299) with videos related to
Sort By:
Page
of 30
Journal of the American College of Cardiology
|
October 29, 2013
AMG 145, a monoclonal antibody against PCSK9, facilitates achievement of national cholesterol education program-adult treatment panel III low-density lipoprotein cholesterol goals among high-risk patients: an analysis from the LAPLACE-TIMI 57 trial (LDL-C assessment with PCSK9 monoclonal antibody inhibition combined with statin thErapy-thrombolysis in myocardial infarction 57)
Nihar R Desai, Robert P Giugliano, Jing Zhou, et al.
Spectrochimica Acta. Part A, Molecular and Biomolecular Spectroscopy
|
November 9, 2007
EPR spin probe study of polymer associative systems
A M Wasserman, L L Yasina, M V Motyakin, et al.
European Journal of Heart Failure
|
October 10, 2009
The safety and tolerability of darbepoetin alfa in patients with anaemia and symptomatic heart failure
Marc Klapholz, William T Abraham, Jalal K Ghali, et al.
American Journal of Public Health
|
November 2, 2018
Trends and Racial Disparities of Late-Stage HIV Diagnosis: Hawaii, 2010-2016
Fenfang Li, Brandi K Juan, Michelle Wozniak, et al.
Parasitology Research
|
May 9, 2018
Prevalence and genotyping of Echinococcus granulosus in sheep in Narok County, Kenya
D O Odongo, C M Tiampati, E Mulinge, et al.
The Journal of Nutrition, Health & Aging
|
June 9, 2020
Editorial: Diagnostic Testing for SARS-Coronavirus-2 in the Nursing Facility: Recommendations of a Delphi Panel of Long-Term Care Clinicians
M Wasserman, J G Ouslander, A Lam, et al.
Nature
|
October 20, 1994
Long-term uncoupling of chloride secretion from intracellular calcium levels by Ins(3,4,5,6)P4
M Vajanaphanich, C Schultz, M T Rudolf, et al.
Journal of Clinical Pharmacology
|
November 19, 2016
Impact of Target-Mediated Elimination on the Dose and Regimen of Evolocumab, a Human Monoclonal Antibody Against Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9)
John P Gibbs, Sameer Doshi, Mita Kuchimanchi, et al.
Journal of the American College of Cardiology
|
April 3, 2014
Anti-PCSK9 monotherapy for hypercholesterolemia: the MENDEL-2 randomized, controlled phase III clinical trial of evolocumab
Michael J Koren, Pernille Lundqvist, Michael Bolognese, et al.
American Heart Journal
|
February 28, 2016
Rationale and design of the Further cardiovascular OUtcomes Research with PCSK9 Inhibition in subjects with Elevated Risk trial
Marc S Sabatine, Robert P Giugliano, Anthony Keech, et al.
Page
of 30